14fxL

Key Stories from the past week: A Golden Milestone

Macro

Less noise from the Oval Office this week but the tariff tit-for-tat continues. Volatility is the outcome sparking investor nerves but also presenting market opportunities. Gold is the haven winner reaching $3,000. Similar to last week, Nasdaq futures saw heavy trading on the Saxo platform as the underlying index remains under pressure (-10% ytd). This week Novo Nordisk topped the list for the most trading clients with a strong skew to the buy side at lows not seen since 2023. US inflation numbers were soft, while positive for rate cuts it is a fear for growth. More below on this week’s key stories. 


Breaking $3,000
Gold reaches record $3,000 per ounce as investors flock into havens on potential growth impact of tariffs. Gold bullion-backed ETF holdings rose to about 2,687 tons which is most since Nov 2023.
Gold surges past USD 3,000 as haven demand grows

Wall Street’s “Fear Guage”
At the time of writing, VIX is at 24 and has a 1-week average of 25.96, this versus the long-term average of around 19.5. Fuelled by trade wars and market uncertainty, volatility can provide short-term fear while long-term investors should remain focused.
Volatility Explained
How to stay on track in a volatile market

EUR strength continues
Last week’s fiscal U-turn initiated the rally in Euro, and news flow continues to reinforce that rhetoric. The fundamentals indicate support could push EURUSD to a multi-year range of 1.12+, but for now the rally takes a breath.
Where does EURUSD find support?

Roche/Zealand pact
Zealand Pharma’s pact with Roche to co-develop and co-commercialise the Danish company’s experimental obesity drug Petrelintide adds another big player to the weight loss drug market. Shares in Novo Nordisk fell - 4.3% on the news to close at a 52-week low.
Roche boosts drug pipeline


Next week will again be led by political and geopolitical developments. We should have clarity over the next US spending bill while tariff spats and talks over a ceasefire in Ukraine continue. The economic calendar brings US Feb Retail Sales on Monday. Bank of Japan rate decision, EU Feb CPI and then US FOMC rate decision on Wednesday. Swiss and Bank of England rate decisions will be announced on Thursday. Scheduled earnings include several prominent Chinese companies XPeng, Tencent Music (Tues), PDD Holdings (Thurs), Nio Inc (Fri). In the US we highlight Nike, Micron, Fedex, which are all due out Thursday.

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.